Related Experiment Video
Updated: May 1, 2026

Inducible and Reversible Dominant-negative DN Protein Inhibition
Published on: January 7, 2019
A retinoblastoma allele that is mutated at its common E2F interaction site inhibits cell proliferation in
Matthew J Cecchini1, Michael J Thwaites, Srikanth Talluri
1London Regional Cancer Program, Western University, London, Ontario, Canada.
Abstract:
The retinoblastoma protein (pRB) is best known for regulating cell proliferation through E2F transcription factors. In this report, we investigate the properties of a targeted mutation that disrupts pRB interactions with the transactivation domain of E2Fs. Mice that carry this mutation endogenously (Rb1(ΔG)) are defective for pRB-dependent repression of E2F target genes. Except for an accelerated entry into S phase in response to serum stimulation, cell cycle regulation in Rb1(ΔG/ΔG) mouse embryonic fibroblasts (MEFs) strongly resembles that of the wild type. In a serum deprivation-induced cell cycle exit, Rb1(ΔG/ΔG) MEFs display a magnitude of E2F target gene derepression similar to that of Rb1(-/-) cells, even though Rb1(ΔG/ΔG) cells exit the cell cycle normally. Interestingly, cell cycle arrest in Rb1(ΔG/ΔG) MEFs is responsive to p16 expression and gamma irradiation, indicating that alternate mechanisms can be activated in G1 to arrest proliferation. Some Rb1(ΔG/ΔG) mice die neonatally with a muscle degeneration phenotype, while the others live a normal life span with no evidence of spontaneous tumor formation. Most tissues appear histologically normal while being accompanied by derepression of pRB-regulated E2F targets. This suggests that non-E2F-, pRB-dependent pathways may have a more relevant role in proliferative control than previously identified.
Insights
The retinoblastoma protein (pRB) mutation disrupts E2F interactions, affecting cell cycle control. While some mice show muscle issues, most live normally, suggesting pRB has roles beyond E2F regulation.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- The retinoblastoma protein (pRB) is a key regulator of cell proliferation, primarily through its interaction with E2F transcription factors.
- Understanding pRB's functions is crucial for comprehending cell cycle control and cancer development.
Purpose of the Study:
- To investigate the functional consequences of a specific mutation disrupting pRB's interaction with the transactivation domain of E2Fs.
- To elucidate the role of pRB-E2F interactions in cell cycle regulation and organismal development.
Main Methods:
- Generation and analysis of mice with a targeted mutation in the pRB gene (Rb1(ΔG)).
- Assessment of cell cycle progression, gene expression (E2F targets), and cell cycle arrest mechanisms in mouse embryonic fibroblasts (MEFs).
- Histological and survival analysis of Rb1(ΔG/ΔG) mice.
Main Results:
- Rb1(ΔG/ΔG) MEFs exhibit defective pRB-dependent repression of E2F target genes and accelerated S-phase entry upon serum stimulation.
- Despite derepression of E2F targets during cell cycle exit, Rb1(ΔG/ΔG) MEFs arrest normally, indicating functional redundancy.
- Cell cycle arrest in Rb1(ΔG/ΔG) MEFs remains responsive to p16 and gamma irradiation.
- Some Rb1(ΔG/ΔG) mice display neonatal muscle degeneration, but most have normal lifespan and no tumors, with tissues showing derepressed E2F targets.
Conclusions:
- Disruption of pRB-E2F interactions impairs repression of E2F targets but does not abolish cell cycle control.
- pRB utilizes mechanisms independent of E2F transactivation for critical cellular functions.
- Non-E2F-dependent pRB pathways play a significant role in maintaining normal tissue homeostasis and preventing tumor formation.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
Negative Regulator Molecules
Inhibition of Cdk Activity
Abnormal Proliferation
Mitogens and the Cell Cycle

